The present situation of endocrine therapy in premenopausal patients with positive hormone receptor breast cancer
10.11904/j.issn.1002-3070.2017.02.015
- VernacularTitle:绝经前激素受体阳性乳腺癌内分泌治疗现状
- Author:
Lei SHI
- Keywords:
Breast cancer;
Premenopausal;
Endocrine therapy
- From:Practical Oncology Journal
2017;31(2):170-174
- CountryChina
- Language:Chinese
-
Abstract:
Endocrine therapy is one of the important treatments of adjuvant therapy among patients with positive hormone receptor breast cancer.In the endocrine therapy setting,5 years of tamoxifen therapy has been the standard treatment regimen for premenopausal patients.In recent years,this standard has been challenged.The results of many large randomized clinical trials have made a new choice for adjuvant endocrine therapy in premenopausal patients.In this paper,we review the present situation of endocrine therapy in premenopausal patients with positive hormone receptor breast cancer.
